These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 7376087

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Morvan's fibrillary chorea after gold therapy].
    Fraisse P, Sutter B, Tritschler JL, Niederberger P, Kuntz JL, Asch L.
    Presse Med; 1985 May 11; 14(19):1097. PubMed ID: 3158970
    [No Abstract] [Full Text] [Related]

  • 44. [A comparative evaluation of parenteral and oral preparations of gold and D-penicillamine in the treatment of rheumatoid nephropathy].
    Chichasova NV, Kanevskaia MZ, Slobodina GA, Varshavskiĭ VA, Krel' OV, Krel' AA.
    Ter Arkh; 1991 May 11; 63(5):97-101. PubMed ID: 1679571
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Gold-induced aplastic anemia.
    Williame LM, Joos R, Proot F, Immesoete C.
    Clin Rheumatol; 1987 Dec 11; 6(4):600-5. PubMed ID: 3449312
    [Abstract] [Full Text] [Related]

  • 51. [Continuous chrysotherapy of rheumatoid disease (evaluation of a retrospective study of 42 cases)].
    D'eshougues JR, Delcambre B, Maquerlot M, Defrance D.
    Lille Med; 1977 Dec 11; 22(7):430-8. PubMed ID: 412025
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis.
    Perrier P, Raffoux C, Thomas P, Tamisier JN, Busson M, Gaucher A, Streiff F.
    Ann Rheum Dis; 1985 Sep 11; 44(9):621-4. PubMed ID: 3876081
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Serum IgE concentration and other immune manifestations of treatment with gold salts are linked to the MHC and IL4 regions in the rat.
    Kermarrec N, Dubay C, De Gouyon B, Blanpied C, Gauguier D, Gillespie K, Mathieson PW, Druet P, Lathrop M, Hirsch F.
    Genomics; 1996 Jan 01; 31(1):111-4. PubMed ID: 8808287
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Hepatitis secondary to a gold salt overdose].
    Jaeger A, Porte A, Sauder P, Stoeckel ME, Mantz JM.
    Gastroenterol Clin Biol; 1984 Jan 01; 8(8-9):660-6. PubMed ID: 6489687
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Prolonged cholestasis and ductopenia following gold salt therapy.
    Basset C, Vadrot J, Denis J, Poupon J, Zafrani ES.
    Liver Int; 2003 Apr 01; 23(2):89-93. PubMed ID: 12654130
    [Abstract] [Full Text] [Related]

  • 60. Subcellular localization of gold in suprarenal testicle and thyroid glands after injection of allochrysine in rats.
    Manoubi L, Jaafoura MH, Skhiri-Zhioura A, el Hili A, Berry JP, Galle P.
    Cell Mol Biol (Noisy-le-grand); 1994 Jun 01; 40(4):483-7. PubMed ID: 7914784
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.